Bristol-Myers Squibb Company (BMY) — Cash Flow-to-Debt Ratio
Bristol-Myers Squibb Company (BMY) has a Cash Flow-to-Debt Ratio of 0.02x as of March 2026, meaning its operating cash flow of $1.10 Billion could theoretically repay 0% of its total liabilities ($66.37 Billion) in one year. See BMY cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bristol-Myers Squibb Company Cash Flow-to-Debt Ratio (1989–2025)
Historical debt coverage capacity for Bristol-Myers Squibb Company across 37 annual periods. Also explore BMY year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bristol-Myers Squibb Company (1989–2025)
Year-by-year debt coverage analysis for Bristol-Myers Squibb Company. For market capitalisation and broader financial context, see market value of Bristol-Myers Squibb Company.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | $14.16 Billion | $71.53 Billion | ▼ -0.7% |
| 2024 | 0.20x | $15.19 Billion | $76.22 Billion | ▼ -5.6% |
| 2023 | 0.21x | $13.86 Billion | $65.67 Billion | ▲ +6.1% |
| 2022 | 0.20x | $13.07 Billion | $65.70 Billion | ▼ -10.0% |
| 2021 | 0.22x | $16.21 Billion | $73.31 Billion | ▲ +26.8% |
| 2020 | 0.17x | $14.05 Billion | $80.60 Billion | ▲ +69.1% |
| 2019 | 0.10x | $8.07 Billion | $78.25 Billion | ▼ -69.6% |
| 2018 | 0.34x | $7.07 Billion | $20.86 Billion | ▲ +39.4% |
| 2017 | 0.24x | $5.28 Billion | $21.70 Billion | ▲ +38.0% |
| 2016 | 0.18x | $3.06 Billion | $17.36 Billion | ▲ +45.0% |
| 2015 | 0.12x | $2.10 Billion | $17.32 Billion | ▼ -27.6% |
| 2014 | 0.17x | $3.15 Billion | $18.77 Billion | ▲ +10.5% |
| 2013 | 0.15x | $3.54 Billion | $23.36 Billion | ▼ -51.3% |
| 2012 | 0.31x | $6.94 Billion | $22.26 Billion | ▲ +10.2% |
| 2011 | 0.28x | $4.84 Billion | $17.10 Billion | ▼ -2.7% |
| 2010 | 0.29x | $4.49 Billion | $15.44 Billion | ▲ +16.1% |
| 2009 | 0.25x | $4.07 Billion | $16.22 Billion | ▲ +16.8% |
| 2008 | 0.21x | $3.71 Billion | $17.28 Billion | ▲ +6.2% |
| 2007 | 0.20x | $3.15 Billion | $15.61 Billion | ▲ +51.1% |
| 2006 | 0.13x | $2.08 Billion | $15.58 Billion | ▲ +23.3% |
| 2005 | 0.11x | $1.84 Billion | $16.93 Billion | ▼ -30.9% |
| 2004 | 0.16x | $3.18 Billion | $20.23 Billion | ▼ -21.1% |
| 2003 | 0.20x | $3.51 Billion | $17.66 Billion | ▲ +242.3% |
| 2002 | 0.06x | $945.00 Million | $16.27 Billion | ▼ -82.4% |
| 2001 | 0.33x | $5.40 Billion | $16.32 Billion | ▼ -40.2% |
| 2000 | 0.55x | $4.65 Billion | $8.40 Billion | ▲ +11.1% |
| 1999 | 0.50x | $4.22 Billion | $8.47 Billion | ▲ +14.7% |
| 1998 | 0.43x | $3.78 Billion | $8.70 Billion | ▲ +36.3% |
| 1997 | 0.32x | $2.48 Billion | $7.76 Billion | ▼ -1.9% |
| 1996 | 0.33x | $2.64 Billion | $8.12 Billion | ▲ +5.6% |
| 1995 | 0.31x | $2.50 Billion | $8.11 Billion | ▼ -3.5% |
| 1994 | 0.32x | $2.30 Billion | $7.21 Billion | ▼ -23.7% |
| 1993 | 0.42x | $2.58 Billion | $6.16 Billion | ▼ -1.2% |
| 1992 | 0.42x | $2.03 Billion | $4.78 Billion | ▼ -16.3% |
| 1991 | 0.51x | $1.83 Billion | $3.62 Billion | ▲ +9.8% |
| 1990 | 0.46x | $1.75 Billion | $3.80 Billion | ▲ +32.3% |
| 1989 | 0.35x | $1.19 Billion | $3.41 Billion | — |